DK1383526T3 - Immuniseringsterapi til behandling af aterosklerose - Google Patents

Immuniseringsterapi til behandling af aterosklerose

Info

Publication number
DK1383526T3
DK1383526T3 DK02714667T DK02714667T DK1383526T3 DK 1383526 T3 DK1383526 T3 DK 1383526T3 DK 02714667 T DK02714667 T DK 02714667T DK 02714667 T DK02714667 T DK 02714667T DK 1383526 T3 DK1383526 T3 DK 1383526T3
Authority
DK
Denmark
Prior art keywords
treatment
atherosclerosis
immunization therapy
cardiovascular diseases
peptides
Prior art date
Application number
DK02714667T
Other languages
Danish (da)
English (en)
Inventor
Prediman K Shah
Jan Nilsson
Original Assignee
Forskarpatent I Syd Ab
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0101232A external-priority patent/SE0101232D0/sv
Application filed by Forskarpatent I Syd Ab, Cedars Sinai Medical Center filed Critical Forskarpatent I Syd Ab
Application granted granted Critical
Publication of DK1383526T3 publication Critical patent/DK1383526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK02714667T 2001-04-05 2002-04-05 Immuniseringsterapi til behandling af aterosklerose DK1383526T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0101232A SE0101232D0 (sv) 2001-04-05 2001-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein
SE0103754A SE0103754L (sv) 2001-04-05 2001-11-09 Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
PCT/SE2002/000679 WO2002080954A1 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein

Publications (1)

Publication Number Publication Date
DK1383526T3 true DK1383526T3 (da) 2009-03-30

Family

ID=26655437

Family Applications (3)

Application Number Title Priority Date Filing Date
DK02714667T DK1383526T3 (da) 2001-04-05 2002-04-05 Immuniseringsterapi til behandling af aterosklerose
DK08151489.5T DK2006301T3 (da) 2001-04-05 2002-04-05 Peptid-baseret immuniseringsterapi til behandling af atherosklerose
DK10181267.5T DK2295464T3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for the treatment of atherosclerosis targeting ApoB100

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK08151489.5T DK2006301T3 (da) 2001-04-05 2002-04-05 Peptid-baseret immuniseringsterapi til behandling af atherosklerose
DK10181267.5T DK2295464T3 (en) 2001-04-05 2002-04-05 Peptide-based immunization therapy for the treatment of atherosclerosis targeting ApoB100

Country Status (18)

Country Link
EP (42) EP2289929A1 (sv)
JP (6) JP2004529143A (sv)
CN (4) CN1505525B (sv)
AT (2) ATE510851T1 (sv)
AU (1) AU2002246484B8 (sv)
BR (1) BR0208685A (sv)
CA (3) CA2606839C (sv)
CY (1) CY1108817T1 (sv)
DE (1) DE60230029D1 (sv)
DK (3) DK1383526T3 (sv)
EE (2) EE200700052A (sv)
ES (2) ES2546293T3 (sv)
IL (4) IL158285A0 (sv)
PL (4) PL367301A1 (sv)
PT (1) PT1383526E (sv)
RU (1) RU2296582C2 (sv)
SE (1) SE0103754L (sv)
WO (1) WO2002080954A1 (sv)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
KR20040081418A (ko) 2001-09-28 2004-09-21 에스페리온 테라피유틱스 인코포레이티드 약물의 국소투여를 통한 재협착의 예방 및 치료
AU2003267905B2 (en) * 2002-10-04 2009-02-05 Biolnvent International Ab Peptide-based passive immunization therapy for treatment of atherosclerosis
SE0302312D0 (sv) * 2002-10-04 2003-08-27 Forskarpatent I Syd Ab Peptide-based passive immunization therapy for treatment of atherosclerosis
SE0302422D0 (sv) 2003-09-11 2003-09-11 Forskarpatent I Syd Ab Peptide-based immunization therapy for treatment of atherosclerosis
SE0400683D0 (sv) 2004-03-19 2004-03-19 Forskarpatent I Syd Ab Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis
WO2005097206A2 (en) 2004-04-06 2005-10-20 Cedars-Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
CN1968965B (zh) 2004-04-15 2015-12-16 阿瑟拉生物技术公司 磷酸胆碱偶联物和相应抗体
EP1676602A1 (en) * 2005-01-04 2006-07-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis
GB0517878D0 (en) 2005-09-02 2005-10-12 Bioinvent Int Ab Immunotherapeutic treatment
BRPI0720215A2 (pt) * 2006-12-22 2013-12-24 Abbott Lab Painel de doença autoimune cardiovascular e métodos de usar o mesmo.
WO2008104194A1 (en) * 2007-02-28 2008-09-04 Bioinvent International Ab Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques
US8536168B2 (en) 2007-03-15 2013-09-17 Novartis Ag Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway
ES2777948T3 (es) * 2007-11-05 2020-08-06 Nordic Bioscience As Marcadores bioquímicos para la evaluación de riesgos de CVD
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
EP3021121B1 (en) * 2008-08-15 2018-06-06 Fujikura Kasei Co., Ltd. Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis
CA2780753A1 (en) * 2009-11-14 2011-05-19 Kuang-Yuh Chyu Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
US8506964B2 (en) 2010-02-05 2013-08-13 Cardiovax, Llc Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
US20130142760A1 (en) 2010-08-18 2013-06-06 Cedars-Sinai Medical Center Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer
EP2637689A2 (en) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
CN103501806A (zh) * 2010-11-12 2014-01-08 赛达斯西奈医疗中心 用于治疗和/或预防动脉瘤的免疫调节方法和系统
EP2637686A2 (en) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100
AU2012294431B2 (en) 2011-08-09 2017-03-30 Athera Biotechnologies Ab Antibodies binding to phosphorylcholine (PC) and/or PC conjugates
PT2742068T (pt) 2011-08-09 2019-07-08 Dyax Corp Novos anticorpos contra fosforilcolina
RU2495048C1 (ru) * 2012-04-18 2013-10-10 Андрей Валентинович Исаев Пептид, обладающий антиатеросклеротическим действием и композиция для профилактики и лечения атеросклероза сосудов
CA2888657C (en) 2012-11-06 2022-05-03 Les Hopitaux Universitaires De Geneve Mimetic peptides
CN103520713B (zh) * 2013-10-16 2015-10-28 西北农林科技大学 一种ApoB100酵母重组疫苗及其制备方法和应用
CN103860470A (zh) * 2014-03-05 2014-06-18 贵州中泰生物科技有限公司 一种口服高密度脂蛋白脂质体的制备方法
CN105315364B (zh) * 2014-06-17 2018-09-18 广州文瑞生物科技有限公司 胶原蛋白vi疫苗预防动脉粥样硬化
US11130798B2 (en) 2015-05-19 2021-09-28 La Jolla Institute For Allergy And Immunology Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN108478817B (zh) * 2018-03-16 2020-10-27 北京大学 一种动脉粥样硬化检测试剂及其制备方法
CA3129373A1 (en) 2018-05-29 2019-12-05 Abcentra, Llc Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970144A (en) 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US5972890A (en) 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
WO1993018067A1 (en) * 1992-03-06 1993-09-16 Abbott Laboratories Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels
WO1994000592A1 (en) * 1992-06-26 1994-01-06 Exocell, Inc. Monoclonal antibodies against glycated low density lipoprotein
EP0671926B1 (en) * 1992-08-11 2002-11-13 President And Fellows Of Harvard College Immunomodulatory peptides
KR0185334B1 (ko) 1995-11-02 1999-04-01 김은영 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9620153D0 (en) * 1996-09-27 1996-11-13 Univ Strathclyde Non-naturally occurring lipoprotein particle
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
US6225070B1 (en) 1997-08-07 2001-05-01 The Regents Of The University Of California Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
US6156315A (en) * 1997-10-10 2000-12-05 The Trustees Of Columbia University In The City Of New York Method for inhibiting the binding of low density lipoprotein to blood vessel matrix
US6309844B1 (en) * 1997-10-15 2001-10-30 Fujirebio Inc. Anti-apo-B-48 monoclonal antibody, hybridoma producing the same, and method for measuring apo-B-48 using the same
EP1062512A4 (en) * 1998-03-10 2001-12-12 Univ California METHODS AND TOOLS USED TO IDENTIFY COMPOUNDS THAT MODULATE ATHEROSCLEROSIS BY ALTERATION OF THE LDL-PROTEOGLYCANE BINDING
WO2000002920A1 (en) * 1998-07-13 2000-01-20 University Of Otago Inhibition of lipoprotein formation
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
DE60045869D1 (de) * 1999-10-26 2011-06-01 Univ California Reagenzien und verfahren für diagnose, 'imaging' und behandlung von atherosklerotischen krankheiten
EP1290217A2 (en) * 2000-02-04 2003-03-12 Aeomica, Inc. Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
CN1418106A (zh) * 2000-03-03 2003-05-14 史密丝克莱恩比彻姆生物有限公司 疫苗
SE0000855D0 (sv) * 2000-03-15 2000-03-15 Karolinska Innovations Ab Antigenic composition useful as a vaccine against atherosclerosis
GB0017641D0 (en) * 2000-07-18 2000-09-06 Medigene Oy Peptides and their use
EP1186299A1 (en) * 2000-09-12 2002-03-13 Universitair Medisch Centrum Utrecht The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system
WO2002048388A2 (en) * 2000-10-25 2002-06-20 Vincent Agnello Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell
AU2002241603A1 (en) * 2000-11-10 2002-06-03 University Of Utah Research Foundation Carrier system for specific artery wall gene delivery
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
CN1312178C (zh) * 2001-05-15 2007-04-25 株式会社Jimro 高密度脂蛋白反应性肽
JP2005504025A (ja) * 2001-07-20 2005-02-10 アイトゲネシシェ テクニシェ ホッヒシュル チューリッヒ（エーテーハーツェット） スルフォネート化またはスルフェート化アミノ酸から誘導された生物学的薬剤の使用法と組成物

Also Published As

Publication number Publication date
JP5300819B2 (ja) 2013-09-25
CA2443223C (en) 2013-11-26
SE0103754D0 (sv) 2001-11-09
EP2289929A1 (en) 2011-03-02
EP2289912A1 (en) 2011-03-02
CN101284874A (zh) 2008-10-15
CA2606839C (en) 2015-06-09
EP2295464B1 (en) 2015-06-03
CN101486766A (zh) 2009-07-22
CN1505525A (zh) 2004-06-16
EP2289925A1 (en) 2011-03-02
EP1918300A2 (en) 2008-05-07
ES2546293T3 (es) 2015-09-22
EP2289935A1 (en) 2011-03-02
IL158285A (en) 2009-12-24
PT1383526E (pt) 2009-02-27
EP2305706A1 (en) 2011-04-06
JP2013144687A (ja) 2013-07-25
EP2147929A3 (en) 2010-04-14
JP2011068654A (ja) 2011-04-07
EP2295463A1 (en) 2011-03-16
DK2295464T3 (en) 2015-08-17
SE0103754L (sv) 2002-10-06
EP2295462A1 (en) 2011-03-16
EP2289933A1 (en) 2011-03-02
EP2289934B1 (en) 2013-11-13
EP2147930A2 (en) 2010-01-27
AU2002246484A1 (en) 2002-10-21
EP1383526B1 (en) 2008-11-26
EP2289931A1 (en) 2011-03-02
JP5270456B2 (ja) 2013-08-21
CA2443223A1 (en) 2002-10-17
PL217858B1 (pl) 2014-08-29
JP2004529143A (ja) 2004-09-24
CN1505525B (zh) 2012-11-07
EP2295461A1 (en) 2011-03-16
PL215401B1 (pl) 2013-12-31
EP2289919A1 (en) 2011-03-02
EP2006301B1 (en) 2011-05-25
EP2305707A1 (en) 2011-04-06
EP2006301A1 (en) 2008-12-24
DE60230029D1 (de) 2009-01-08
EP2295458A1 (en) 2011-03-16
EP2289924A1 (en) 2011-03-02
EP2295464A1 (en) 2011-03-16
CA2827167A1 (en) 2002-10-17
EP1383526A1 (en) 2004-01-28
EP2289920A1 (en) 2011-03-02
CN101284874B (zh) 2012-10-03
EP2147928A2 (en) 2010-01-27
CA2606839A1 (en) 2002-10-17
JP2011063598A (ja) 2011-03-31
IL195356A0 (en) 2009-08-03
EP2289915A1 (en) 2011-03-02
EP2295460B1 (en) 2015-06-03
EP2289926A1 (en) 2011-03-02
AU2002246484B8 (en) 2007-06-14
ATE415423T1 (de) 2008-12-15
WO2002080954A1 (en) 2002-10-17
EP2147930A3 (en) 2010-04-14
PL367301A1 (en) 2005-02-21
EP2289914A1 (en) 2011-03-02
JP2008169215A (ja) 2008-07-24
JP5300820B2 (ja) 2013-09-25
PL400308A1 (pl) 2012-12-17
AU2002246484B2 (en) 2007-04-19
EP2289922A1 (en) 2011-03-02
EP1918300A3 (en) 2009-06-17
EE200300487A (et) 2004-02-16
EP2289913A1 (en) 2011-03-02
EP2289927A1 (en) 2011-03-02
ATE510851T1 (de) 2011-06-15
EP2289917A1 (en) 2011-03-02
EP2295459A1 (en) 2011-03-16
ES2317999T3 (es) 2009-05-01
EP2147928A3 (en) 2010-04-14
EP2305708A1 (en) 2011-04-06
EP2289934A1 (en) 2011-03-02
EP2289918A1 (en) 2011-03-02
EE200700052A (et) 2008-08-15
EP2147680A2 (en) 2010-01-27
EP2289928A1 (en) 2011-03-02
EP2147680A3 (en) 2010-04-14
CN103122031A (zh) 2013-05-29
DK2006301T3 (da) 2011-09-12
EP2289932A1 (en) 2011-03-02
EP2295457A1 (en) 2011-03-16
EP2289916A1 (en) 2011-03-02
JP2009191078A (ja) 2009-08-27
CY1108817T1 (el) 2014-04-09
IL158285A0 (en) 2004-05-12
BR0208685A (pt) 2004-03-30
EP2289930A1 (en) 2011-03-02
RU2003132443A (ru) 2005-02-27
RU2296582C2 (ru) 2007-04-10
EP2289923A1 (en) 2011-03-02
JP5613890B2 (ja) 2014-10-29
EP2295460A1 (en) 2011-03-16
CN103122031B (zh) 2015-07-22
IL188286A0 (en) 2008-03-20
EP2289921A1 (en) 2011-03-02
EP2147929A2 (en) 2010-01-27

Similar Documents

Publication Publication Date Title
DK1383526T3 (da) Immuniseringsterapi til behandling af aterosklerose
BR0315157A (pt) Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste
CY1112229T1 (el) Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β
DK1434791T3 (da) Specifikke bindingsmidler til human angiopoietin-2
SE0401601D0 (sv) Protofibril specific antibodies and uses thereof
NO20025354L (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter
ATE373016T1 (de) Induktion von immunologischer toleranz gegen einen therapeutischen antikörper durch varianten des therapeutischen antikörpers
HK1088909A1 (en) Peptide-based immunization therapy for treatment of atherosclerosis
DK1374895T3 (da) Farmaceutisk sammensætning af F(AB) 2-fragmenter af antistoffer og fremgangsmåde til fremstilling heraf
WO2004030607A3 (en) Peptide-based passive immunization therapy for treatment of atherosclerosis
SE0202959D0 (sv) Peptide-Base passive immunization therapy for treatment of atherosclerosis
DK1275638T3 (da) Kombinationspræparat til behandling af immunologiske sygdomme
BRPI0216033B8 (pt) "terapia de imunização à base de peptídio para tratamento de arteriosclerose"
FR2839721B1 (fr) Antigene polypeptidique induisant des anticorps neutralisant le vih
SE0203226D0 (sv) Immunoglobulin bindning site
ITTO20010795A0 (it) Polipeptide isolato basato sulla sequenza della proteina p17 utile come vaccino anti-hiv.